Phibro Animal Health's stock soared 5.00% during intraday trading on Friday, reflecting significant positive investor sentiment.
The surge appears to be driven by an analyst upgrade, as Bofa Global Research raised its price objective for the company to $38 from $32, indicating increased confidence in the firm's future performance and valuation.